BACKGROUND Type 2 Diabetes Mellitus still remains one of the leading causes of morbidity and mortality. Diabetic patients are prone to osteoporosis. The development of osteoporosis in diabetes is also promoted by the coexistence of chronic microvascular complications of diabetes, which also affect the bone marrow blood vessels. Diabetic osteopathy is a significant comorbidity of diabetes and is characterised by microarchitectural changes that decrease bone quality and reduction of bone strength leading to an increased risk of bone fracture in diabetes. There is high prevalence of vitamin D deficiency and hyperparathyroidism in uncontrolled diabetic patients, which further leads to osteopenia or osteoporosis. Aims and Objectives-To establish correlation between vitamin D, PTH and BMD with diabetic control and complications of type 2 diabetic patients. ). All the patients were subjected to detailed clinical history, examination and relevant investigations like HbA1c, BMD, vitamin D, PTH, urine microscopy, fundus etc. were done in all patients.
concentration (hyperglycaemia). Hyperglycaemia results in the formation of advanced glycation end products (AGEs). These AGEs acts to prime endothelial cells and monocytes, making them more susceptible to stimuli that induce the cells to produce the inflammatory mediators. Accumulation of AGEs in plasma and tissues of diabetic patients has been linked to diabetic complications. The accumulation of advanced glycation end products (AGEs) in collagen leads to inferior bone quality and strength. Furthermore, glycated collagen inhibits expression in osteoblasts. 2 Another indirect effect of hyperglycaemia is glycosuria, which causes hypercalciuria leading to decreased levels of calcium in the body and poor bone quality and fastens bone loss. 3 Osteoporosis is defined as a combination of reduced bone mass and altered bone quality with microarchitectural abnormalities, resulting in decreased bone strength with an increased risk of fractures. 4 Based on the present definition, both bone density and quality, which encompass the structural and material properties of bone are important factors in the determination of bone strength. Diabetic osteopathy is a significant comorbidity of both forms of diabetes and is characterised by microarchitectural changes that decrease bone quality leading to an increased risk of bone fracture in both types of diabetes. 5 The fracture risk of T1DM increases because of a decrease of BMD. 6 In patients with T1DM, the impaired bone formation is a result of absolute deficiency of insulin and insulin-like growth factor-1 (IGF-1), which leads to lower values of peak bone mass. In both types of diabetes, bone displays inferior quality and strength. 7 Dual energy x-ray absorptiometry (DXA) scan can diagnose osteoporosis in the early stages before broken bones can occur. 8 Epidemiological studies in Asian-Indian populations indicate that elderly patients with proximal femoral fractures had high prevalence of vitamin D deficiency and these patients had significantly low BMD compared with healthy controls. These osteoporosis fractures tend to occur earlier in Indian population than in their western counterparts and they are more common in women. It is believed that half of all women and one-third of all men will sustain an osteoporotic fracture during their lifetime. Regardless of the source, however, low level of serum vitamin D can reduce circulating calcium and induce secondary hyperparathyroidism. The increase in PTH may induce weight gain, obesity and T2DM. Raised PTH is associated with abnormal glucose metabolism due to interference of PTH with either with ability of the pancreas to release insulin, the action of insulin or both. High PTH level causes suppression of insulin signal transduction in adipocytes that resulted in insulin resistance and high prevalence of diabetes mellitus (2 -4 times) in hyperparathyroidism. 9 Secondary hyperparathyroidism is a response to low calcium level related to hypovitaminosis D.
The cause of osteoporosis is multifactorial, hyperparathyroidism and vitamin D deficiency are possible risk factor. 10 There is evidence that vitamin D inhibits fat accumulation, increases insulin synthesis and preserves pancreatic islet cells, decreases insulin resistance and reduces hunger, favouring better control of obesity and T2DM both. In bone metabolism, vitamin D increases the plasma levels of calcium and phosphorus, regulates osteoblast and osteoclast activity and combats PTH hypersecretion, promoting bone formation and preventing/treating osteoporosis.
MATERIALS AND METHODS Study Design
Observational study.
Study Setting
Department of Medicine, BRD Medical College, Gorakhpur.
Study Period
January 2017 to December 2017.
Study Subjects
Clinically diagnosed case of type 2 Diabetes Mellitus of age group 45 -65 yrs.
Sample Size 100 patients with Type 2 Diabetes Mellitus.
Inclusion Criteria
A total of 100 clinically diagnosed Type-2 diabetic patients of age group 45 -65 years, who were admitted in Department of Medicine, Nehru Hospital, BRD Medical College, Gorakhpur, UP from Jan 2017 to Dec 2017 were included in this study.
Exclusion Criteria
Type-2 diabetic patients with following conditions were excluded from the study-1. Patients with extensive skin disorders (due to hampered vitamin D synthesis). 2. Post total thyroidectomy patients (because of absent parathyroid gland). 3. Critically ill patients (because of excess oxidative stress and impaired kidney function).
Study Procedure
The patients were selected as per inclusion criteria. An informed consent was taken. Detailed case history, examination and relevant investigations (HbA1C, urine microscopy, BMD, vitamin D, PTH etc.) were done for all patients. Data was collected using a semi-structured questionnaire by direct interview with patients and by clinical examination and from relevant investigations.
Investigations
1. HbA1C level (controlled < 7%, uncontrolled > 7%). 2. Serum PTH (normal 7 -68 pg/mL, increased > 68 pg/mL). 3. Serum vitamin D (normal > 20 ng/mL, low level < 20 ng/mL). 4. BMD: Dual energy x-ray absorptiometry (DXA) scan at lumbar spine (L2 -L4) and dual femur (trochanter and femoral neck) was done and patients were categorised by using WHO criteria as:  Normal BMD T-score: at or above -1 SD.  Osteopenia T-score: between -1 and -2.5 SD.  Osteoporosis T-score: at or below -2.5 SD.
Statistical Analysis
Data entry was done in IBM SPSS Statistics Version 22 and statistical analysis was done by using appropriate statistical tests like Fisher exact test and Pearson Chi-square test by descriptive statistics. P value < 0.05 is considered as statistically significant result.
RESULTS
There was high prevalence of abnormal BMD (total 62%) in diabetic patients. The prevalence of osteoporosis (30%) was more in uncontrolled diabetics (86.67%), while osteopenia (32%) was present in 68.75% of uncontrolled diabetics and 31.25% of controlled diabetics. Vitamin D deficiency was also more in 86.66% of uncontrolled diabetic patients as compared to controlled diabetics (13.33%) (p value= 0.090). In osteoporotic patients, 86.66% of patients had low vitamin D and 66.67% patients had raised PTH, while in osteopenic patients 68.75% had low vitamin D and 37.50% had raised PTH (p value= 0.002). Majority of the osteoporotic patients had raised PTH (66.67%), while most of the osteopenic patients had normal PTH levels (56.25%). 3 also conform that bone loss has been observed to be greater in patients with poorly controlled diabetes than in those whose diabetes is in good control. Study by Mima et al 12 also showed that diabetes mellitus is associated with osteoporosis. As shown in Table 2 , among 40 (40%) patients with normal Vitamin D 14 (35%) patients had controlled Diabetes and 26 (65%) patients had uncontrolled Diabetes and 60 (60%) with low vitamin D, 8 (13.33%) had controlled diabetes and 52 (86.66%) had uncontrolled diabetes. It was found that vitamin D deficiency was more common in uncontrolled diabetic patients (86.66%) (p value= 0.090). Similarly, in a study by Mohammad Alhumaidi et al, 13 it was found that prevalence of vitamin D deficiency is 76.6% in diabetic patients.
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In Table 3 among 30 patients with osteoporosis, 26 (86.67%) had low vitamin D and 4 (13.33%) had normal vitamin D level in this group of osteoporotic patients, 20 (66.67%) had increased PTH, 10 (33.33%) had normal PTH. In this group of 20 patients in whom vitamin D was decreased and PTH was raised all were osteoporosed, while in 4 cases with osteoporosis, neither vitamin D was decreased nor PTH was raised. This signifies that osteoporosis also depend on some other factors like increasing age, female gender, menopause, low BMI, low calcium diet, lack of exercise, decreased sunlight exposure, medications like steroid, glitazones etc. Patients who had both raised PTH and low vitamin D were more prone to develop osteoporosis than the patients who had either raised PTH or low Vitamin D alone.
Similarly, in 32 patients with osteopenia, 22 (68.75%) had low vitamin D and 10 (31.2%) had normal vitamin D. In this group of patients, only 12 (37.5%) had increased PTH and 18 (56.25%) had normal PTH which signifies that low vitamin D level is the better predictor of osteopenia than PTH level. By these findings, we can predict that those patients who had both low level of vitamin D and increased PTH will be osteoporosed or osteopenic. It means that PTH and vitamin D together are better predictors of osteoporosis or osteopenia.
Similar results were shown by many other studies. The study done by Sahota et al 14 found that prevalence of hypovitaminosis D was 39% and not all patients with hypovitaminosis D develop secondary hyperparathyroidism. Patel et al 15 suggested that glomerular filtration rate is the single most important factor in maintaining PTH levels. Gunnarsson et al, 16 while supporting the kidney function hypothesis, felt that body mass index may play a role in women by blunting the level of PTH and added that in men insulin-like growth factor 1, smoking and testosterone levels may do the same. The World Health Organisation (WHO) 17 described a serum level of 25-OHD of 20 ng/mL (50 nmol/L) as deficiency 17 and a level of 30 ng/mL (75 nmol/L) as normal, because at this level PTH drops down to normal levels. At present it is believed that below 30 ng/mL of 25-OHD, the level of PTH should start rising. 18 A study done by Chang et al 9 shows that high level of PTH is associated with abnormal glucose metabolism due to interference of PTH either with ability of the pancreas to release insulin, the action of insulin or both. High PTH level causes suppression of insulin signal transduction in adipocytes that resulted in insulin resistance and high prevalence of diabetes mellitus ( 4. Most of the patients with osteoporosis had raised PTH with low vitamin D level both of which further worsens blood sugar control. 5. By this study we can predict that in those patients who had both low level of vitamin D and increased PTH were more prone to develop osteoporosis or osteopenic. It means that PTH and vitamin D together are better predictors of osteoporosis or osteopenia.
